Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 155

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 3
Chunk 155
---
Rx Ltd. 2003 Amended and Restated Share Incentive Plan. In January 2016, our board of directors
approved amendments to the Plan in order to permit the granting RSUs and PSUs to eligible grantees. In November 2023, our board of directors
approved a six-month extension of the term of the Plan until May 2024 and, in May 2024, our board of directors approved a further extension
until May 2044. References below to the “ Plan” refer to the Plan as amended in August 2013, January 2016, November 2023
and May 2024.

The Plan provides for the granting of options, ordinary shares, RSUs and PSUs to our
directors, employees, consultants and service providers, and to the directors, employees, consultants and service providers of our subsidiaries
and affiliates. The Plan provides for equity grants to be made at the determination of our board of directors in accordance with applicable
law. As of March 16, 2025, options to purchase 107,746,200 ordinary shares or 179,577 ADSs, an aggregate 13,832,400 PSUs or 23,054 ADSs
and an aggregate of 9,588,600 RSUs or 15,981 ADSs were outstanding under the Plan.

From time to time, our board of directors has approved an increase in the number of
shares reserved for the purpose of equity grants pursuant to the Plan. As of March 16, 2025, 68.9 million ordinary shares, or 0.1 million
ADSs, were reserved for future issuance under the Plan.

The Plan is administered by our board of directors for the purposes
of making equity grants and approving the terms of those grants, including, exercise price (in the case of options), vesting schedule,
acceleration of vesting and the other matters necessary in the administration of the Plan. Equity grants made under the Plan to eligible
employees and office holders who are Israeli residents are made under Section 102 of the Israeli Income Tax Ordinance [New Version], 5721-1961,
or the Israeli Tax Ordinance, pursuant to which the securities granted must be allocated or issued to a trustee and be held in trust for
two years from the date of grant. Under Section 102 of the Israeli Tax Ordinance, any tax payable by an employee from the grant of securities
or the exercise of options or vesting